Haleon emerges from GSK consumer healthcare spin-off
Split illustrates move towards narrower focus in pharmaceuticals
GSK’s consumer health spin-off, Haleon, has begun trading as a separate company, after the pharmaceuticals giant’s shareholders approved the split in early July. The business covers a broad portfolio of brands such as Panadol painkillers and Sensodyne toothpaste.